Julia A Elvin

Julia A Elvin

UNVERIFIED PROFILE

Are you Julia A Elvin?   Register this Author

Register author
Julia A Elvin

Julia A Elvin

Publications by authors named "Julia A Elvin"

Are you Julia A Elvin?   Register this Author

67Publications

3034Reads

25Profile Views

Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma.

Cancer Discov 2018 07 17;8(7):822-835. Epub 2018 May 17.

Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-18-0099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030433PMC
July 2018

Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer.

Case Rep Oncol 2018 May-Aug;11(2):399-403. Epub 2018 Jun 22.

Division of Hematology and Oncology, Mayo Clinic Hospital, Phoenix, Arizona, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000490238DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047557PMC
June 2018

Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.

Cold Spring Harb Mol Case Stud 2018 04 2;4(2). Epub 2018 Apr 2.

Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, Rutgers Cancer Institute of New Jersey/Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a002089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880253PMC
April 2018

Comprehensive Analysis of Hypermutation in Human Cancer.

Cell 2017 Nov 19;171(5):1042-1056.e10. Epub 2017 Oct 19.

Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2017.09.048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849393PMC
November 2017

reversion mutation acquired after treatment identified by liquid biopsy.

Gynecol Oncol Rep 2017 Aug 21;21:57-60. Epub 2017 Jun 21.

Foundation Medicine, Inc., Cambridge, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2017.06.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496455PMC
August 2017

Elevated tumor mutational burden and prolonged clinical response to anti-PD-L1 antibody in platinum-resistant recurrent ovarian cancer.

Gynecol Oncol Rep 2017 Aug 27;21:78-80. Epub 2017 Jun 27.

Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2017.06.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510487PMC
August 2017

A recurrent endometrial stromal sarcoma harbors the novel fusion .

Gynecol Oncol Rep 2017 May 8;20:51-53. Epub 2017 Mar 8.

Department of Obstetrics and Gynecology and the Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2017.03.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348601PMC
May 2017

Comprehensive genomic profiling (CGP) of ovarian clear cell carcinomas (OCCC) identifies clinically relevant genomic alterations (CRGA) and targeted therapy options.

Gynecol Oncol Rep 2017 May 1;20:62-66. Epub 2017 Mar 1.

Cancer Treatment Centers of America at Eastern Regional Medical Center, Philadelphia, PA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2017.02.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357688PMC
May 2017

Genomic profiling of gynecologic cancers and implications for clinical practice.

Curr Opin Obstet Gynecol 2017 02;29(1):18-25

aDivision of Gynecologic Oncology, University of California Los Angeles, Los Angeles, California bFoundation Medicine, Inc., 150 Second Street, Cambridge, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GCO.0000000000000335DOI Listing
February 2017

Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic Melanoma.

Am J Dermatopathol 2017 Jan;39(1):1-13

*Professor of Pathology and Dermatology, Albany Medical College, Albany, NY; †Pathology Resident, Unversidade Estadual Paulista, Botucatu, Brazil; ‡Pathology Resident, Albany Medical College, Albany, NY; §Director of Research, Associate Professor, Department of Pathology, Albany, Medical College, Albany, NY; ¶Research and Development, Foundation Medicine, Inc, Cambridge, MA; ‖Chief Medical Officer, Foundation Medicine, Inc, Cambridge, MA; #Chief Scientific Officer, Foundation Medicine, Inc, Cambridge, MA; **Associate Medical Officer, Foundation Medicine, Inc, Cambridge, MA; ††Associate Medical Director, Foundation Medicine, Inc, Cambridge, MA; ‡‡Research Scientist, Foundation Medicine, Inc, Cambridge, MA; §§Chief, Professor of Pathology, Albany, Medical College, Albany, NY; and ¶¶Medical Director, Foundation Medicine, Inc, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DAD.0000000000000729DOI Listing
January 2017

Yield and Clinical Utility of Next-Generation Sequencing in Selected Patients With Lung Adenocarcinoma.

Clin Lung Cancer 2016 11 8;17(6):517-522.e3. Epub 2016 Jun 8.

Division of Pulmonary, Allergy and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.05.017DOI Listing
November 2016

Personalized Treatment for a Patient With a BRAF V600E Mutation Using Dabrafenib and a Tumor Treatment Fields Device in a High-Grade Glioma Arising From Ganglioglioma.

J Natl Compr Canc Netw 2016 11;14(11):1345-1350

From Baylor Health Care System, Dallas, Texas; Foundation Medicine, Inc., Cambridge, Massachusetts; Penn Memory Center, Department of Neurology, Philadelphia, Pennsylvania; Albany Medical College, Albany, New York; and UT Southwestern Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0145DOI Listing
November 2016

Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response.

Eur Urol Focus 2016 Jun 9;2(2):204-209. Epub 2015 Dec 9.

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2015.11.007DOI Listing
June 2016

Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets.

J Clin Pathol 2016 May 23;69(5):403-8. Epub 2015 Oct 23.

Department of Pathology, Albany Medical College, Albany, New York, USA Foundation Medicine, Inc., Cambridge, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2015-203394DOI Listing
May 2016

A novel acquired ALK F1245C mutation confers resistance to crizotinib in ALK-positive NSCLC but is sensitive to ceritinib.

Lung Cancer 2016 Feb 3;92:19-21. Epub 2015 Dec 3.

Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA 92868, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.11.023DOI Listing
February 2016

Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.

Oncologist 2016 Jan 15;21(1):33-9. Epub 2015 Dec 15.

Foundation Medicine, Inc., Cambridge, Massachusetts, USA; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California, USA; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA; Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York, USA.

View Article

Download full-text PDF

Source
http://www.foundationmedicine.com/wp-content/uploads/2015/12
Web Search
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2015-0241DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709208PMC
January 2016

Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.

Oncologist 2015 Oct 2;20(10):1132-9. Epub 2015 Sep 2.

Foundation Medicine, Inc., Cambridge, Massachusetts, USA; Division of Hematology-Oncology, University of California Irvine, Orange, California, USA; The Ohio State University-James Cancer Hospital, Columbus, Ohio, USA; National Translational Research Group, New York, New York, USA; Albany Medical College, Albany, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591943PMC
October 2015

FGFR3-TACC3: A novel gene fusion in cervical cancer.

Gynecol Oncol Rep 2015 Aug 18;13:53-6. Epub 2015 Jun 18.

Northwestern Medicine Developmental Therapeutics Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University 645 N Michigan Ave Suite 1006 Chicago, IL, 60611, Unites States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2015.06.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563584PMC
August 2015

A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling.

Am J Surg Pathol 2015 Jun;39(6):858-63

Departments of *Pathology ‡Internal Medicine, Oncology Division, Rhode Island Hospital, and Alpert Medical School at Brown University, Providence, RI †Foundation Medicine Inc., Cambridge, MA §Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000403DOI Listing
June 2015

Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.

Arch Pathol Lab Med 2015 May;139(5):642-9

From the Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York (Drs Ross and Boguniewicz and Ms Sheehan); Research and Development, Foundation Medicine, Inc, Cambridge, Massachusetts (Drs Ross, Wang, Otto, Yelensky, Lipson, Ali, Morosini, Chliemlecki, Elvin, Miller, and Stephens); and the Department of Pathology, University of Indiana School of Medicine, Indianapolis (Dr Badve).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0200-OADOI Listing
May 2015

Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole.

Int J Gynecol Pathol 2008 Apr;27(2):247-51

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/intjgynpathology/2008/04000/Int
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PGP.0b013e3181577dc8DOI Listing
April 2008

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.

J Clin Oncol 2007 Sep;25(25):3985-90

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.12.2622DOI Listing
September 2007

p63 protects the female germ line during meiotic arrest.

Nature 2006 Nov 22;444(7119):624-8. Epub 2006 Nov 22.

Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nature05337
Publisher Site
http://dx.doi.org/10.1038/nature05337DOI Listing
November 2006

Regulation of growth differentiation factor 9 expression in oocytes in vivo: a key role of the E-box.

Biol Reprod 2006 Jun 22;74(6):999-1006. Epub 2006 Feb 22.

Department of Pathology, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1095/biolreprod.105.050013DOI Listing
June 2006

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

Am J Surg Pathol 2006 Feb;30(2):230-6

Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ajsp/2006/02000/The_Tubal_Fimbr
Web Search
http://dx.doi.org/10.1097/01.pas.0000180854.28831.77DOI Listing
February 2006

Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility.

Mol Endocrinol 2002 Jun;16(6):1154-67

Department of Pathology, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/mend.16.6.0859DOI Listing
June 2002